header("Access-Control-Allow-Origin: *"); ?>
therapeuticpublished patents
oncologypublished patents
research tools
diagnosticpublished patents
Welcome to our Technology Offers website You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.
Diagnostic
Research
Therapeutic
Flow Cytometry
Immunocytochemistry
Immunoprecipitation
In vivo studies
Western Blot
Cardiovascular Diseases
Central Nervous System
Dermatology
Ear nose throat disease
Gastrointestinal Diseases
Genetic Disorders
Genito Urinary System
Hematological Disorders
Immunology
Musculoskeletal
Nutritional disorder
Oncology
Ophtalmology
Respiratory Disease
Women health
Others
Infectious diseases
The present invention relates to antibodies or fragments thereof that specifically bind to glycoprotein (GP) of Ebola virus, and to their use for […]
The present invention concerns lentiviral vectors enabling the expression of membrane-anchored and secreted antibodies by B cells. This invention […]
The present inventions relate to - metallated porphyrin derivatives as ligands of G quadruplex and their use as anti-viral agents. Porphyrin […]
The present invention relates to vaccine compositions comprising an attenuated mutant Zika virus. The inventors have introduced mutations at very […]
Septic shock is the leading cause of death in intensive care units. Previous studies have highlighted the immunosuppressive protein GILZ […]
Tuberculosis (TB), caused by M. tuberculosis infection, continues to be one of the most prevalent infectious diseases worldwide. The WHO has also […]
Escherichia coli O25b-ST131 clone is a worldwide pandemic clone, causing predominantly community-onset antimicrobial-resistant infection. A high […]
Hepatitis E virus (HEV) is the leading cause of enterically transmitted viral hepatitis globally, and is responsible for 20 million infections and […]
Carbapenemase-producing bacteria isolates are increasingly identified throughout the world. Their early detection is becoming a major issue in the […]
The present invention relates to a method for treating an infection, particularly HCMV infection. To date, there are very few reports on the role of […]
In the present invention inventors used measured cytokine levels in serum of patients with COVID-19, […]
In the present invention, inventors investigate the representation of neutrophil subsets in severe […]
Coronaviridae is a family of enveloped, positive-sense, single-stranded RNA viruses. The viral […]
In the present invention, inventors report the characterization of BCLA (Brain Cyst Load-associated […]
The present invention concerns an inhibitor for use for preventing and/or treating an infection with […]
The present invention relates to a genomic sequences encoding for an attenuated mutant Zika virus. […]
Septic shock is the leading cause of death in intensive care units. Previous studies have […]
The invention relates to mAb based chimeric proteins allowing direct in-vivo targeting of antigens […]
Hepatitis E virus (HEV) is the leading cause of enterically transmitted viral hepatitis globally, […]
The present invention relates to a method for treating an infection, particularly HCMV infection. To […]
Research tool licensing team
researchtools@inserm-transfert.fr
User accounts are momentarily unavailable
The Inserm Transfert website is currently undergoing maintenance. It will be available again in a few hours.